Market for Medical Device Technologies Is Likely to be Valued at US$ 663 Billion by 2032

Medical Device Technologies Market Analysis Report By Device Type (IVD Devices, Cardiology, Diagnostic Imaging, Orthopedic Devices, Diabetes Care Devices), By End User (Hospitals, Clinics, Diagnostic Centers), By Region - Global Insights 2022-2032

The market for medical device technologies is expected to grow at a Y-o-Y rate of 4.6% in 2022 to reach US$ 491.95 billion. The industry is predicted to grow at a CAGR of 3% from 2022 to 2032 and reach a worth of US$ 663 billion.

The medical device technologies market experienced a modest CAGR of 4.3% from 2015 to 2021. Over time, non-invasive and minimally invasive (MI) diagnostic tools have become increasingly common. Today, MI procedures are becoming more common, especially when treating solid tumours in cancer patients. These procedures result in fewer side effects, a reduced chance of infection, less discomfort, and a quicker recovery.

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4828?SP

Which Device Type will Leverage Medical Device Technologies the Most?

Deployment to be Maximum across Diabetes Care Devices

Diabetes care device sales are expected to grow the quickest, with a positive CAGR of 4% over the projected period. Demand for diagnostic imaging devices, on the other hand, is expected to catch up, with a CAGR of 5.9% through 2032. Diabetes care equipment sales are increasing due to the increased prevalence of lifestyle disorders such as diabetes among a diverse population globally.

According to the World Health Organization and the International Diabetes Federation (IDF), more than 400 million individuals have diabetes in 2014. The use of diagnostic imaging techniques such as MRI, X-ray, and CT scan allows for the non-invasive diagnosis of chronic illnesses. This aspect is a major driver of the increase in diagnostic imaging device sales.

Competitive Landscape:

The worldwide market for medical device technology is fragmented, with multiple medical device makers competing for collaboration with hospitals, clinics, and research organizations. Due to low switching costs for hospitals and the availability of identical products from other vendors, the level of competition is considerable.

• Medtronic plc, Johnson & Johnson, Siemens Healthineers, GE Healthcare, F. Hoffmann La Roche Ltd., Phillips Healthcare, Baxter International, Boston Scientific Corporation, Abbott Laboratories, and Cardinal Health are some of the major competitors in the medical device technology industry. Development of sophisticated medical technology continues to be a primary priority area for industry leaders seeking to preserve a strategic position.
• Boston Scientific Corporation's structural heart treatment is one of the fastest expanding areas of the medical device technologies industry. The segment has a high level of synergy with the rhythm management and interventional cardiology businesses. Similarly, Baxter International is planning to launch around 50 items over the next five years, including acute and renal care solutions with increased technology enhancements.

Key Segments Covered in the Medical Device Technologies Industry Report:

·         Medical Device Technologies by Device Type

• In-Vitro Medical Diagnostic (IVD) Devices
• Cardiology Devices
• Diagnostic Imaging Devices
• Orthopedic Devices
• Ophthalmology Devices
• Endoscopy Devices
• Diabetes Care Devices
• Wound Management Devices
• Kidney/Dialysis Devices
• Anesthesia and Respiratory Care Devices
• Others

·         Medical Device Technologies by End User

• Academics & Research

• Hospitals

• Clinics

• Diagnostic Centers

• Ambulatory Surgery Centers

• Others

·         Medical Device Technologies by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa (MEA)

For in-depth competitive analysis, Buy Now:
https://www.factmr.com/checkout/4828

Key Takeaways from the Market Study

• Diabetes care device sales are increasing at a healthy rate, with a CAGR of 4% expected for the projection period. This is due to the increased proportion of the diabetes population worldwide.
• Medical device technology adoption in hospitals continues to drive growth strategies, accounting for more than 30% of total market revenue.
• Rising healthcare infrastructure investment has resulted in a rise in the number of hospitals built to provide modern medical treatment. This is expected to be a significant growth determinant.
• North America will continue its dominance in the medical device technologies industry, accounting for over two-fifths of the worldwide market value.
• The Asia-Pacific region is predicted to provide significant potential prospects for leading players, with the market developing at a CAGR of 5.6% through 2032.
• The rising frequency of chronic illnesses, as well as the growing elderly population, is driving market development in both areas.